Skip to content
1 (234) 567-891info@the7psy.com
Search:
Monday – Friday 10 AM – 8 PM
Twitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new windowRss page opens in new window
European Menopause and Andropause Society
European Menopause and Andropause Society
European Menopause and Andropause Society
  • Home
  • About EMAS
  • What we do
    • EMAS Courses and Schools
    • EMAS sessions in International Congresses
    • Upcoming EMAS Webinars
    • EMAS Webinar replay
  • Guidelines and education
    • EMAS Position Statements
    • EMAS Clinical Guides
    • EMAS Care Online 2020
    • EMAS Educational Materials 2020
    • EMAS and Menopause in the Workplace 2021
    • Non EMAS Educational Materials
    • EMAS Webinar replay – Spanish
  • News
    • Articles
    • IMS and NAMS: News and Statements
    • OBGYN News
    • European Medicine Agency (EMA)
    • EMAS News
    • Press releases
    • Newsletter
  • EMAS Membership
    • EMAS Membership
    • Join EMAS
    • Maturitas Journal
  • Junior Section
  • Congresses / Courses
  • Contact
  • Home
  • About EMAS
  • What we do
    • EMAS Courses and Schools
    • EMAS sessions in International Congresses
    • Upcoming EMAS Webinars
    • EMAS Webinar replay
  • Guidelines and education
    • EMAS Position Statements
    • EMAS Clinical Guides
    • EMAS Care Online 2020
    • EMAS Educational Materials 2020
    • EMAS and Menopause in the Workplace 2021
    • Non EMAS Educational Materials
    • EMAS Webinar replay – Spanish
  • News
    • Articles
    • IMS and NAMS: News and Statements
    • OBGYN News
    • European Medicine Agency (EMA)
    • EMAS News
    • Press releases
    • Newsletter
  • EMAS Membership
    • EMAS Membership
    • Join EMAS
    • Maturitas Journal
  • Junior Section
  • Congresses / Courses
  • Contact

Daily Archives: July 30, 2020

You are here:
  1. Home
  2. 2020
  3. July
  4. 30

Menopausal Hormone Therapy and breast cancer risk: Individualization is the key to safety

EMAS NewsBy adminJuly 30, 2020Leave a comment

Online on 12 August the editorial written by Eleni Armeni, Antonio Cano, Margaret Rees and Irene Lambrinoudaki after publication of 20 year WHI follow up data concludes that that estrogen monotherapy is safe in the long-term with regard to breast cancer risk. The need to use progestogens with a better breast safety profile, such as…

EMAS ADMINISTRATIVE OFFICE
c/o K.I.T. Group GmbH · Association & Conference Management
Kurfürstendamm 71
D - 10709 Berlin
  • Phone:
    +49 (0)30 24603-0
  • Email:
    info@emas-online.org

Find us on:

Twitter page opens in new windowYouTube page opens in new windowLinkedin page opens in new window
@ EMAS 2018
  • Privacy Policy
Privacy Policy
Go to Top
X